Thyroid Eye Disease (TED): Clinical Trials

1 trial for Thyroid Eye Disease (TED), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Thyroid Eye Disease (TED): new trials by email Literature Review of Thyroid Eye Disease (TED) trials Research Report on Thyroid Eye Disease (TED)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
VV-14305, Sham (No Treatment) - Thyroid Eye Disease (TED)
Phase 1 / Phase 2RecruitingKriya Therapeutics, Inc.1352026-05-012026-08-27

Narrower conditions

Graves Ophthalmopathy (1)

Broader conditions

Autoimmune Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine System Diseases (1)  ·  Exophthalmos (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Goiter (1)  ·  Graves Disease (1)  ·  Hyperthyroidism (1)  ·  Immune System Diseases (1)  ·  Orbital Diseases (1)  ·  Thyroid Diseases (1)

Interventions

salicylhydroxamic acid (1)

Sponsors

Kriya Therapeutics, Inc. (1)

Countries

New Zealand (1)  ·  United States (1)